Tag: Enveda Biosciences

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

June 14, 2024 03:00 AM Pacific Daylight Time BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences (“Enveda”), a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add…

Read More Read More

Enveda Biosciences has filed a notice of an exempt offering of securities to raise $62,459,761.00 in New Equity Investment.

Enveda Biosciences has filed a notice of an exempt offering of securities to raise $62,459,761.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Enveda Biosciences is raising $62,459,761.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Viswa Colluru played a key role…

Read More Read More